But interestedly, Patients with biallelic inactivating mutations in RIPK1, including missense, nonsense, and frameshift mutations, exhibit symptoms of inflammatory bowel disease and combined immunodeficiency, develop lymphopenia, and display increased sensitivity to TNFR1-mediated cell death (21, 22). The gene discussed is RIPK1; the disease is inflammatory bowel disease.